Clinical Trial Update: ROTATEQ™ Post-Marketing Surveillance in the Philippines

View source ↗

Summary

Post-marketing surveillance study of ROTATEQ in the Philippines has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteritis
• Rotavirus Infections

Drugs mentioned

• RotaTeq (rotavirus vaccine, pentavalent)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Rotavirus Infections, Gastroenteritis | Status: TERMINATED